Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Weeks, Multi-center, Open Label, Randomized, Active Drug Parallel Control Trial to Compare the Effectiveness of Valsartan/Amlodipine and Nifedipine in Treating Chinese Hypertensive Patients Not Respond to Mono Antihypertensive Treatment

NCT01167153 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT01167153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01167153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Weeks, Multi-center, Open Label, Randomized, Active Drug Parallel Control Trial to Compare the Effectiveness of Valsartan/Amlodipine and Nifedipine in Treating Chinese Hypertensive Patients Not Respond to Mono Antihypertensive Treatment
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2010
Completion date
April 30, 2011
Enrollment
564 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension